HC Wainwright & Co. Reiterates Buy on Assembly Biosciences, Maintains $50 Price Target
HC Wainwright & Co. analyst Patrick R. Trucchio reiterates Assembly Biosciences (NASDAQ:ASMB) with a Buy and maintains $50 price target.
Read original at benzingaStocks · News reference
8-K filing — ASSEMBLY BIOSCIENCES, INC. (ASMB)
Filed: 2026-08-13 AccNo: 0001193125-26-349198 Size: 460 KB Item 2.01: Completion of Acquisition or Disposition of Assets Item 9.01: Financial Statements and Exhibits
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- edgar
- Observed
- Aug 13, 2026, 8:11 PM
- Checked
- Aug 13, 2026, 8:11 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
8-K/A filing — ASSEMBLY BIOSCIENCES, INC. (ASMB)
Filed: 2026-08-14 AccNo: 0001193125-26-352193 Size: 466 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Read original at edgarAssembly Biosciences Q2 EPS $(0.20) Beats $(0.65) Estimate, Sales $13.374M Beat $8.599M Estimate
Assembly Biosciences (NASDAQ:ASMB) reported quarterly losses of $(0.20) per share which beat the analyst consensus estimate of $(0.65) by 69.23 percent. This is a 84.96 percent increase over losses of $(1.33) per share
Read original at benzinga